Search

Daniel Michael Podgorski

Examiner (ID: 7354, Phone: (571)272-6270 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1628
Total Applications
339
Issued Applications
186
Pending Applications
0
Abandoned Applications
153

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10820414 [patent_doc_number] => 20160166578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'METHOD FOR TREATING TYPE I AND TYPE II DIABETES' [patent_app_type] => utility [patent_app_number] => 14/436674 [patent_app_country] => US [patent_app_date] => 2013-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7999 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436674 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/436674
METHOD FOR TREATING TYPE I AND TYPE II DIABETES Oct 20, 2013 Abandoned
Array ( [id] => 9422442 [patent_doc_number] => 20140107093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE' [patent_app_type] => utility [patent_app_number] => 14/053737 [patent_app_country] => US [patent_app_date] => 2013-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18193 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053737 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/053737
Compounds useful as inhibitors of ATR kinase Oct 14, 2013 Issued
Array ( [id] => 9409040 [patent_doc_number] => 20140100292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets' [patent_app_type] => utility [patent_app_number] => 14/048439 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5015 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048439 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/048439
Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets Oct 7, 2013 Abandoned
Array ( [id] => 9408984 [patent_doc_number] => 20140100236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets' [patent_app_type] => utility [patent_app_number] => 14/048445 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14285 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048445 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/048445
Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets Oct 7, 2013 Abandoned
14/040266 COMPOSITION AND METHOD OF TREATING SKIN CONDITIONS Sep 26, 2013 Abandoned
Array ( [id] => 9319364 [patent_doc_number] => 20140051702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis' [patent_app_type] => utility [patent_app_number] => 13/967389 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 48630 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967389 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/967389
Use of aminoindane compounds in treating overactive bladder and interstitial cystitis Aug 14, 2013 Issued
Array ( [id] => 9496793 [patent_doc_number] => 08735611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Crystalline forms of cabazitaxel' [patent_app_type] => utility [patent_app_number] => 13/965015 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 8832 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965015 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/965015
Crystalline forms of cabazitaxel Aug 11, 2013 Issued
Array ( [id] => 9319395 [patent_doc_number] => 20140051733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/964731 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6418 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964731 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/964731
FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS Aug 11, 2013 Abandoned
13/964033 USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE DISORDERS INCLUDING NICOTINE ADDICTION Aug 8, 2013 Abandoned
Array ( [id] => 9307263 [patent_doc_number] => 20140045937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID' [patent_app_type] => utility [patent_app_number] => 13/960999 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4576 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960999 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/960999
METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID Aug 6, 2013 Abandoned
Array ( [id] => 9464012 [patent_doc_number] => 20140128439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'Methods for Treating Gout Flares' [patent_app_type] => utility [patent_app_number] => 13/961848 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12598 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961848 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/961848
Methods for Treating Gout Flares Aug 6, 2013 Abandoned
Array ( [id] => 10102661 [patent_doc_number] => 09138431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Methods of treatment of histamine H-4 receptor-related pruritus' [patent_app_type] => utility [patent_app_number] => 13/960114 [patent_app_country] => US [patent_app_date] => 2013-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4981 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960114 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/960114
Methods of treatment of histamine H-4 receptor-related pruritus Aug 5, 2013 Issued
Array ( [id] => 9384577 [patent_doc_number] => 20140088059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'Compositions and Methods for Localized Drug Delivery through Mammary Papillae' [patent_app_type] => utility [patent_app_number] => 13/942686 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 21281 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942686 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/942686
Compositions and methods for localized drug delivery through mammary papillae Jul 14, 2013 Issued
Array ( [id] => 9149077 [patent_doc_number] => 20130303600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/941932 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3772 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/941932
Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients Jul 14, 2013 Issued
Array ( [id] => 12942406 [patent_doc_number] => 09833426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function [patent_app_type] => utility [patent_app_number] => 14/411169 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5173 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14411169 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/411169
Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function Jun 27, 2013 Issued
Array ( [id] => 10272651 [patent_doc_number] => 20150157648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2' [patent_app_type] => utility [patent_app_number] => 14/410754 [patent_app_country] => US [patent_app_date] => 2013-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26478 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410754 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/410754
NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2 Jun 25, 2013 Abandoned
Array ( [id] => 9263327 [patent_doc_number] => 20130345255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'TRPV1 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/922442 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25862 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922442 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/922442
TRPV1 antagonists Jun 19, 2013 Issued
Array ( [id] => 12924469 [patent_doc_number] => 09827201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Natural lubricant for direct compression and method for preparing natural tablet using the same [patent_app_type] => utility [patent_app_number] => 13/871529 [patent_app_country] => US [patent_app_date] => 2013-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3184 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13871529 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/871529
Natural lubricant for direct compression and method for preparing natural tablet using the same Apr 25, 2013 Issued
Array ( [id] => 13644611 [patent_doc_number] => 09848599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Co-crystals of 3-iodopropynyl butylcarbamate [patent_app_type] => utility [patent_app_number] => 14/391504 [patent_app_country] => US [patent_app_date] => 2013-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 7196 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391504 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/391504
Co-crystals of 3-iodopropynyl butylcarbamate Apr 8, 2013 Issued
Array ( [id] => 11886919 [patent_doc_number] => 09757465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Composition comprising an organic diluent and a cellulose ether' [patent_app_type] => utility [patent_app_number] => 14/390049 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12331 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390049 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/390049
Composition comprising an organic diluent and a cellulose ether Apr 7, 2013 Issued
Menu